|
⚲
|
| Keyboard |
| Lunate Holding RSC Ltd
✚
|
|
|---|---|
| CIK # | 0002009522 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Revolution Medicines Inc | 53.4 | ||
| SailPoint Inc | 39.7 | ||
| Lineage Inc | 19.7 | ||
| Neumora Therapeutics Inc | 4.1 | ||
| Navan Inc | 2.6 | ||
| Revolution Medicines Inc | 0.8 | ||
| Holdings by Sector ($M) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0002009522] | |
| 13F-NT | [0002009522] | |
| 3 | [0002009522] | |
| 4 | [0002009522] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Alto Neuroscience Inc ANRO
Common Stock
|
2024-02-06 | Buy | 600,000 | $16.00 | 9,600,000 |
|
Alto Neuroscience Inc ANRO
Common Stock
|
2024-02-06 | Conversion | 1,144,762 | ||
|
Alto Neuroscience Inc ANRO
Common Stock
|
2024-02-06 | Conversion | 1,962,995 | ||
|
Alto Neuroscience Inc ANRO
Series B Convertible Preferred Stock (Series B Preferred) · derivative
|
2024-02-06 | Conversion | 1,962,995 | $0.00 | |
|
Alto Neuroscience Inc ANRO
Series C Convertible Preferred Stock (Series C Preferred) · derivative
|
2024-02-06 | Conversion | 1,144,763 | $0.00 |